Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
Main Authors: | Leask, A, Xu, S, Renzoni, E, Bou-Gharios, G, du Bois, R, Abraham, D, Black, C |
---|---|
Format: | Conference item |
Published: |
2005
|
Similar Items
-
Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
by: Shiwen, X, et al.
Published: (2006) -
Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
by: S. Soldano, et al.
Published: (2011-01-01) -
Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
by: Alix Naert, et al.
Published: (2013-01-01) -
CTGF overexpressing mice: a model for human scleroderma
by: Sonnylal, S, et al.
Published: (2006) -
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
by: Emma Di Poi, et al.
Published: (2023-11-01)